136 related articles for article (PubMed ID: 7928458)
1. Proliferative cell nuclear antigen in postradiotherapy prostate biopsies.
Crook J; Robertson S; Esche B
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):303-8. PubMed ID: 7928458
[TBL] [Abstract][Full Text] [Related]
2. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.
Crook J; Malone S; Perry G; Bahadur Y; Robertson S; Abdolell M
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):355-67. PubMed ID: 10974448
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.
Crook J; Robertson S; Collin G; Zaleski V; Esche B
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):31-7. PubMed ID: 7690016
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma.
Crook JM; Bahadur YA; Robertson SJ; Perry GA; Esche BA
Cancer; 1997 Jan; 79(1):81-9. PubMed ID: 8988730
[TBL] [Abstract][Full Text] [Related]
5. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.
Crook JM; Perry GA; Robertson S; Esche BA
Urology; 1995 Apr; 45(4):624-31; discussion 631-2. PubMed ID: 7716843
[TBL] [Abstract][Full Text] [Related]
6. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.
Crook JM; Bahadur YA; Bociek RG; Perry GA; Robertson SJ; Esche BA
Cancer; 1997 Jan; 79(2):328-36. PubMed ID: 9010106
[TBL] [Abstract][Full Text] [Related]
8. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
10. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.
Kestin LL; Goldstein NS; Vicini FA; Mitchell C; Gustafson GS; Stromberg JS; Chen PY; Martinez AA
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):107-18. PubMed ID: 12182980
[TBL] [Abstract][Full Text] [Related]
11. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy.
Forman JD; Oppenheim T; Liu H; Montie J; McLaughlin PW; Porter AT
Prostate; 1993; 23(3):235-43. PubMed ID: 7694267
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for localized prostate cancer: assessment of results by systematic biopsy and PSA.
Crook J; Perry G; Robertson S; Esche B
Can J Urol; 1996 Mar; 3(1):195-201. PubMed ID: 12741978
[TBL] [Abstract][Full Text] [Related]
13. Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy.
Ljung G; Norberg M; Hansson H; de la Torre M; Egevad L; Holmberg L; Busch C; Nilsson S
Acta Oncol; 1995; 34(7):945-52. PubMed ID: 7492386
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
[TBL] [Abstract][Full Text] [Related]
15. Percent free prostate-specific antigen after radiotherapy for prostate cancer.
Crook JM; Bunting PS
Urology; 1998 Jul; 52(1):100-5. PubMed ID: 9671878
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.
Prestidge BR; Hoak DC; Grimm PD; Ragde H; Cavanagh W; Blasko JC
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):31-9. PubMed ID: 9054874
[TBL] [Abstract][Full Text] [Related]
17. Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial.
Kass-Iliyya A; Jovic G; Murphy C; Fisher C; Syndikus I; Jose C; Scrase CD; Graham JD; Nicol D; Sydes MR; Dearnaley D
Eur Urol; 2018 Jun; 73(6):968-976. PubMed ID: 29307509
[TBL] [Abstract][Full Text] [Related]
18. Detection of residual prostate cancer after external radiotherapy. Role of prostate specific antigen and transrectal ultrasonography.
Babaian RJ; Kojima M; Saitoh M; Ayala AG
Cancer; 1995 Apr; 75(8):2153-8. PubMed ID: 7535185
[TBL] [Abstract][Full Text] [Related]
19. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
20. Patterns of local failure following prostate brachytherapy.
Stone NN; Stock RG; White I; Unger P
J Urol; 2007 May; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
